Publications by authors named "Ahmet Burhan Aksakal"

Article Synopsis
  • Psoriasis is a chronic skin condition linked to systemic inflammation, with SII and SIRI being new biomarkers for measuring this inflammation.
  • The study evaluated 220 psoriasis patients and found that biological treatments significantly decreased both SII and SIRI three months after initiation, especially in those treated with various biological agents.
  • Findings suggest that SII and SIRI may reflect psoriasis severity and are associated with other health conditions, highlighting their potential use in selecting and monitoring treatment strategies for psoriasis patients.
View Article and Find Full Text PDF

Background/purpose: Mycosis fungoides (MF) is the most common variant of cutaneous T-cell lymphomas primarily involving the skin. Early-stage MF is characterised by non-specific skin lesions and non-diagnostic biopsies. While skin-focused treatments, such as PUVA and narrowband UVB (nbUVB), are the most frequently recommended treatments, the UVA1 efficacy has been researched in recent years.

View Article and Find Full Text PDF

Leg ulcers are a significant cause of morbidity and mortality and can be caused by vascular, neuropathic, infectious, and traumatic factors, as well as rare metabolic diseases like prolidase deficiency. Despite various wound care methods and systemic treatments, managing ulcers can be challenging. This case presents a male patient with prolidase deficiency for 35 years whose leg ulcers were resistant to standard treatments such as wound dressings, topical treatments, and hyperbaric oxygen therapy.

View Article and Find Full Text PDF
Article Synopsis
  • High serum uric acid levels are linked to psoriasis, cardiovascular diseases, and metabolic syndrome, prompting this study to evaluate how biologic treatments affect these levels in psoriasis patients.
  • The study analyzed 224 patients over about three years, finding that uric acid levels were notably higher in men, overweight/obese individuals, and those with severe psoriasis.
  • After 3 months of treatment with various biologic agents, average serum uric acid levels decreased significantly, suggesting these treatments may help reduce cardiovascular and metabolic risks in psoriasis patients.*
View Article and Find Full Text PDF

Leg ulcers affect millions of people worldwide, and are a significant cause of morbidity and mortality. Various factors can be etiological agents of leg ulcers such as vascular, neuropathic, infectious, and traumatic factors. Treatment of the leg ulcer can be difficult in some cases despite using different systemic treatments and local wound care, but various newly defined treatment modalities are discussed in the literature and topical insulin application is one of them.

View Article and Find Full Text PDF

Background: There aren't many reported skin changes associated with teriflunomide use in patients with multiple sclerosis (MS) mm Only one life-threatening gross skin change has been reported so far; a patient with toxic epidermal necrolysis. There are also a few case reports about cutaneous adverse effects of teriflunomide, such as eczema, rash and palmar pustular psoriasis.

Methods: We herein report the first case of bullous drug reaction in a patient receiving teriflunomide treatment.

View Article and Find Full Text PDF

Background: Recent studies have shown that human beta-defensin-1 (hBD-1) and (human beta-defensin-2 hBD-2), which are antimicrobial peptides produced by the skin, play a role in the pathogenesis of acne vulgaris (AV).

Objective: The aim of this study was to determine the role of antimicrobial peptides in the pathogenesis of AV and enlighten the effects of doxycycline and isotretinoin in the expression of these defensins in AV.

Materials And Methods: A total of 44 patients (22 patients in each group) with Grade 6 and 8 AV who were indicated doxycycline or isotretinoin for their treatment, and 20 healthy volunteers were included in this study.

View Article and Find Full Text PDF

Alopecia universalis (AU) is generally considered a variant of alopecia areata (AA), in which the treatment options seldom provide satisfactory results. However, successful treatment of several cases of AA and its variants with oral Janus kinase (JAK) inhibitors have been reported recently. Here we report a 23-year-old female patient with AU successfully treated with tofacitinib, a selective JAK-3 inhibitor.

View Article and Find Full Text PDF